Effectiveness of Extracorporeal Shockwave Therapy Combined With Platelet-rich Plasma in the Treatment of Chronic Insertional Achilles Tendinopathy - Trial NCT06384859
Access comprehensive clinical trial information for NCT06384859 through Pure Global AI's free database. This Phase 4 trial is sponsored by Mahidol University and is currently Not yet recruiting. The study focuses on Insertional Achilles Tendinopathy. Target enrollment is 94 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Mahidol University
Timeline & Enrollment
Phase 4
May 01, 2024
May 01, 2027
Primary Outcome
VAS
Summary
The goal of this clinical trial is to learn about the effectiveness of extracorporeal
 shockwave(ESWT) combined with platelet-rich plasma(PRP) to treat chronic insertional
 tendinopathy. The main questions it aims to answer are:
 
 Does ESWT combined with PRP treatment reduce the symptom and improve functional score after
 treatment? What medical complication do participants have when receive the treatment?
 
 Researchers will compare ESWT combined with PRP to ESWT treatment alone to see if ESWT
 combined with PRP works to treat chronic insertional tendinopathy.
 
 Participants will:
 
 - Receive ESWT once a week for 4 weeks then receive PRP injection at a week later or ESWT
 once a week for 4 weeks
 
 - Visit the clinic at 6 weeks, 3 months, 6 months and 1 year after treatment for checkups
 and record functional score
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06384859
Device Trial